izpis_h1_title_alt

Adverse outcomes of the newly emerging bisphenol A substitutes
ID Franko, Nina (Avtor), ID Kodila, Anja (Avtor), ID Sollner Dolenc, Marija (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (2,95 MB)
MD5: 1FF404FB1BAE45362DE727E2607794DD
URLURL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S0045653524020447 Povezava se odpre v novem oknu

Izvleček
BPA and its analogues are facing increasingly stringent regulations restricting their use due to the increasing knowledge of their harmful effects. It is therefore expected that novel BPA analogues and alternatives will replace them in plastic products, cans and thermal paper to circumvent restrictions imposed by legislation. This raises concerns about the safety of "BPA-free" products, as they contain BPA substitutes whose safety has not been sufficiently assessed prior to their market introduction. The regulatory agencies have recognised BPAP, BPBP, BPC2, BPE, BPFL, BPG, BPP, BPPH, BPS-MAE, BPS-MPE, BP-TMC, BPZ and the alternatives BTUM, D-90, UU and PF201 as compound with insufficient data regarding their safety. We demonstrate that the mentioned compounds are present in consumer products, food and the environment, thus exhibiting toxicological risk not only to humans, but also to other species where their toxic effects have already been described. Results of in silico, in vitro and in vivo studies examining the endocrine disruption and other effects of BPA analogues show that they disrupt the endocrine system by targeting various nuclear receptors, impairing reproductive function and causing toxic effects such as hepatotoxicity, altered behaviour and impaired reproductive function. In vitro and in vivo data on BPA alternatives are literally non-existent, although these compounds are already present in commonly used thermal papers. However, in silico studies predicted that they might cause adverse effects as well. The aim of this article is to comprehensively collate the information on selected BPA substitutes to illustrate their potential toxicity and identify safety gaps.

Jezik:Angleški jezik
Ključne besede:BPA substitutes, thermal paper, endocrine disruption, adverse outcomes, bisphenol occurrence, Pergafast 201
Vrsta gradiva:Članek v reviji
Tipologija:1.02 - Pregledni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2024
Št. strani:15 str.
Številčenje:Vol. 346, art. 143147
PID:20.500.12556/RUL-160335 Povezava se odpre v novem oknu
UDK:612.43:615.065
ISSN pri članku:0045-6535
DOI:10.1016/j.chemosphere.2024.143147 Povezava se odpre v novem oknu
COBISS.SI-ID:205121539 Povezava se odpre v novem oknu
Datum objave v RUL:26.08.2024
Število ogledov:183
Število prenosov:65
Metapodatki:XML DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Chemosphere
Skrajšan naslov:Chemosphere
Založnik:Elsevier
ISSN:0045-6535
COBISS.SI-ID:25213696 Povezava se odpre v novem oknu

Licence

Licenca:CC BY-NC 4.0, Creative Commons Priznanje avtorstva-Nekomercialno 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc/4.0/deed.sl
Opis:Licenca Creative Commons, ki prepoveduje komercialno uporabo, vendar uporabniki ne rabijo upravljati materialnih avtorskih pravic na izpeljanih delih z enako licenco.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:BPA nadomestki, termo papir, endokrine motnje, neželeni učinki, pojav bisfenola, Pergafast 201, hormonski motilci, stranski učinki

Projekti

Financer:EC - European Commission
Program financ.:HE
Številka projekta:101057014
Naslov:Partnership for the Assessment of Risks from Chemicals
Akronim:PARC

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Program financ.:Young researchers

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:N1-0363
Naslov:Nadomestki bisfenola A: zdravstvena tveganja za endokrini in kardiovaskularni sistem (akronim: BPAsubRisk)

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0208
Naslov:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj